XENITRA LIMITED (ASX: XEN)
Consumer discretionary · News and insights
Price unavailable
Latest XEN announcements
2026-11-06 · Consumer discretionary
XEN: $0.002 +0.00% · MC: $14M
Xenitra’s November investor presentation outlines plans to expand its pharmaceutical and Web3 commerce businesses, following September-quarter pharmaceutical sales of approximately $864,000 and more than $2 million in Web3 sales since April, as reported in its recent quarterly update. The presentation describes pharmaceutical margin potential of 20% to 40% and Web3 margins of 40% to 90%; these are stated profiles, not reported realised margins.
Updated 2026-11-06 12:01
Sources
Investor Presentation - November 2026Comments
2026-10-30 · Consumer discretionary
XEN: $0.002 +0.00% · MC: $14M
Xenitra reported positive quarterly gross profit, reversing a loss in the same quarter last year, as its newly operational pharmaceuticals division generated approximately $864,000 in sales. The company says its three-year procurement agreements provide for at least $12 million in purchases and target a further $5 million, while Web3 partnerships have supported more than $2 million in sales since April. Quarter-end bank cash rose 9% from June and more than doubled year on year to approximately $3 million.
Updated 2026-10-30 16:42
Sources
Quarterly Activities/Appendix 4C Cash Flow ReportComments
Comments